You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Low and Intermediate-1 Risk Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

Recruiting
  • Pre-fibrotic Myelofibrosis
  • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
  • Taipei, Taiwan, 100, Taiwan
    National Taiwan University Hospital
Feb 7, 2023

Leukemia, Myeloid, Acute Trial in Jerusalem (Vyxeos, Mylotarg)

Recruiting
  • Leukemia, Myeloid, Acute
  • Jerusalem, Yerushalayim, Israel
    Shaare Zedek Medical Center
Oct 25, 2022

MDS, MDS, Thrombocytopenia Trial (Placebo, Romiplostim)

Completed
Has Results
  • MDS
  • +2 more
  • Placebo
  • Romiplostim
  • (no location specified)
Nov 4, 2022

Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

Not yet recruiting
  • Rhabdomyosarcoma
  • Palo Alto, California
  • +2 more
Aug 27, 2023

Breast Cancer Trial in Rozzano (external beams radiotherapy, brachytherapy)

Recruiting
  • Breast Cancer
  • external beams radiotherapy
  • brachytherapy
  • Rozzano, Milano, Italy
    IRCCS Istituto Clinico Humanitas
Jan 13, 2023

Anal Squamous Cell Carcinoma Trial (Radiotherapy - Low risk group, Radiotherapy - Standard risk group, Radiotherapy -

Not yet recruiting
  • Anal Squamous Cell Carcinoma
  • Radiotherapy - Low risk group
  • +3 more
  • (no location specified)
Sep 18, 2023

Prostate Cancer Trial in Greenfield Park (HDR brachytherapy as monotherapy)

Completed
  • Prostate Cancer
  • HDR brachytherapy as monotherapy
  • Greenfield Park, Quebec, Canada
    Hôpital Charles LeMoyne
Mar 15, 2022

Prostate Cancer Trial in Candiolo (Robotic hemi-prostatectomy with urethral preservation)

Recruiting
  • Prostate Cancer
  • Robotic hemi-prostatectomy with urethral preservation
  • Candiolo, TO, Italy
    Fondazione del Piemonte per l'Oncologia
Apr 16, 2023

Prostate Cancer Trial in Roma (Soractelite Echolaser Transperineal focal laser ablation)

Recruiting
  • Prostate Cancer
  • Soractelite Echolaser Transperineal focal laser ablation
  • Roma, RM, Italy
    San Carlo di Nancy Hospital
Oct 16, 2022

Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary

Recruiting
  • Pulmonary Embolism
  • Tissue Plasminogen Activator, Alteplase
  • Low-molecular weight heparin
  • İzmir, Bornova/İzmir, Turkey
    Ege University
Aug 22, 2022

Non-Hodgkin's Lymphoma Trial in New York (Etoposide, carboplatin, ifosfamide, Rituximab, Ifosfamide, Etoposide, Carboplatin,

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Etoposide, carboplatin, ifosfamide
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 23, 2022

Prostate Cancer Trial in Chapel Hill (68Ga-HBED-CC-PSMA)

Recruiting
  • Prostate Cancer
  • Chapel Hill, North Carolina
    University of North Carolina - Chapel Hill
Jan 31, 2023

Prostate Cancer Trial (SUPR-SABR treatment)

Not yet recruiting
  • Prostate Cancer
  • SUPR-SABR treatment
  • (no location specified)
Dec 20, 2022

Leukemia Trial in Houston (Decitabine, Azacitidine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 1, 2020

Localized Prostate Cancer, Low Risk Prostate Cancer, Intermediate Risk Prostate Cancer Trial (3 fractions of prostate SBRT)

Not yet recruiting
  • Localized Prostate Cancer
  • +2 more
  • 3 fractions of prostate SBRT
  • (no location specified)
Oct 31, 2023

Low or Intermediate Risk Prostate Cancer Trial in Toronto (Advanced imaging for radiotherapy planning and guidance)

Active, not recruiting
  • Low or Intermediate Risk Prostate Cancer
  • Advanced imaging for radiotherapy planning and guidance
  • Toronto, Ontario, Canada
    University Health Network
Oct 21, 2022

Anemia in MDS Trial in Plantation, Bronx, Austin (TP-0184)

Completed
  • Anemia in Myelodysplastic Syndromes
  • Plantation, Florida
  • +2 more
Apr 4, 2022

Anemia, MDS, Chronic Myelomonocytic Leukemia Trial in France, United States (Sotatercept)

Completed
Has Results
  • Anemia
  • +5 more
  • Denver, Colorado
  • +19 more
Oct 20, 2022

Prostate Cancer Trial in Kelowna (Low dose rate prostate brachytherapy, High Dose Rate prostate brachytherapy)

Recruiting
  • Prostate Cancer
  • Low dose rate prostate brachytherapy
  • High Dose Rate prostate brachytherapy
  • Kelowna, British Columbia, Canada
    British Columbia Cancer Agency Center for the Southern Interior
Mar 3, 2022

CT-FFR Compared to CCTA or CCTA and Stress MPI in Low to

Enrolling by invitation
  • Coronary Artery Disease
  • +3 more
  • Toshiba CT-FFR
  • Manhasset, New York
    North Shore University Hospital
Oct 25, 2022

MDS Trial (Imetelstat)

Available
  • Myelodysplastic Syndromes
  • (no location specified)
Jun 30, 2023

Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)

Recruiting
  • Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
  • Ocala, Florida
  • +3 more
Jan 30, 2023

Pulmonary Embolism Trial in Bispebjerg, Copenhagen, Herlev (Alteplase 20 Mg Powder for Solution for Injection Vial, Ultrasound

Recruiting
  • Pulmonary Embolism
  • Alteplase 20 Mg Powder for Solution for Injection Vial
  • Ultrasound assisted Thrombolysis
  • Bispebjerg, Denmark
  • +2 more
Oct 25, 2022

Chemo Effect, Rectal Cancer Trial in Guangzhou (Radical total mesorectal excision, Salavge Adjuvant Chemoradiotherapy)

Recruiting
  • Chemotherapy Effect
  • Rectal Cancer
  • Radical total mesorectal excision
  • Salavge Adjuvant Chemoradiotherapy
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Sep 12, 2023

Hodgkin Disease Trial in Houston (ABVE-PC, DECA)

Active, not recruiting
  • Hodgkin Disease
  • Houston, Texas
    Texas Children's Hospital
Jan 19, 2022